Journal
BRITISH JOURNAL OF CANCER
Volume 98, Issue 5, Pages 989-991Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bjc.6604240
Keywords
aspirin; breast cancer; incidence
Categories
Funding
- NCI NIH HHS [CA-47988, R01 CA047988] Funding Source: Medline
- NHLBI NIH HHS [R01 HL043851] Funding Source: Medline
Ask authors/readers for more resources
The Women's Health Study trial previously reported no overall effect of low-dose aspirin (100 mg every other day) on invasive breast cancer over an average of 10 years of treatment. The present subgroup analyses further show no effects by tumour characteristics at diagnosis, suggesting that low-dose aspirin has no preventive effect on breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
